Marie Källström

Marie Källström (born 1966) has more than 25 years of global experience in Regulatory Affairs positions in late-stage pharmaceutical development in companies such as Pfizer, AstraZeneca and Pharmacia. The last position was Regulatory Specialist at Novo Nordisk with responsibility for coordinating the development of NDA/MAA documentation as well as planning and participating in several Authority interactions within the development of pharmaceutical products for the treatment of diabetes and obesity.

Marie Joined Ascelia Pharma in 2020 and became a member of the Management Team in 2022.